IL18 and prostate carcinoma: The IL18 promoter polymorphism –137G/C has previously been linked to various cancers in different populations, including esophageal squamous cell malignant tumors, prostate cancer in the Chinese population [20], colorectal cancer in Greek people [21], and ovarian cancer in native Hawaiians [22].